599 related articles for article (PubMed ID: 34009992)
1. Incomplete Systemic Recovery and Metabolic Phenoreversion in Post-Acute-Phase Nonhospitalized COVID-19 Patients: Implications for Assessment of Post-Acute COVID-19 Syndrome.
Holmes E; Wist J; Masuda R; Lodge S; Nitschke P; Kimhofer T; Loo RL; Begum S; Boughton B; Yang R; Morillon AC; Chin ST; Hall D; Ryan M; Bong SH; Gay M; Edgar DW; Lindon JC; Richards T; Yeap BB; Pettersson S; Spraul M; Schaefer H; Lawler NG; Gray N; Whiley L; Nicholson JK
J Proteome Res; 2021 Jun; 20(6):3315-3329. PubMed ID: 34009992
[TBL] [Abstract][Full Text] [Related]
2. Integrative Modeling of Quantitative Plasma Lipoprotein, Metabolic, and Amino Acid Data Reveals a Multiorgan Pathological Signature of SARS-CoV-2 Infection.
Kimhofer T; Lodge S; Whiley L; Gray N; Loo RL; Lawler NG; Nitschke P; Bong SH; Morrison DL; Begum S; Richards T; Yeap BB; Smith C; Smith KGC; Holmes E; Nicholson JK
J Proteome Res; 2020 Nov; 19(11):4442-4454. PubMed ID: 32806897
[TBL] [Abstract][Full Text] [Related]
3. NMR Spectroscopic Windows on the Systemic Effects of SARS-CoV-2 Infection on Plasma Lipoproteins and Metabolites in Relation to Circulating Cytokines.
Lodge S; Nitschke P; Kimhofer T; Coudert JD; Begum S; Bong SH; Richards T; Edgar D; Raby E; Spraul M; Schaefer H; Lindon JC; Loo RL; Holmes E; Nicholson JK
J Proteome Res; 2021 Feb; 20(2):1382-1396. PubMed ID: 33426894
[TBL] [Abstract][Full Text] [Related]
4. Integrative Plasma Metabolic and Lipidomic Modelling of SARS-CoV-2 Infection in Relation to Clinical Severity and Early Mortality Prediction.
Lodge S; Lawler NG; Gray N; Masuda R; Nitschke P; Whiley L; Bong SH; Yeap BB; Dwivedi G; Spraul M; Schaefer H; Gil-Redondo R; Embade N; Millet O; Holmes E; Wist J; Nicholson JK
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511373
[TBL] [Abstract][Full Text] [Related]
5. Maintained imbalance of triglycerides, apolipoproteins, energy metabolites and cytokines in long-term COVID-19 syndrome patients.
Berezhnoy G; Bissinger R; Liu A; Cannet C; Schäfer H; Kienzle K; Bitzer M; Häberle H; Göpel S; Trautwein C; Singh Y
Front Immunol; 2023; 14():1144224. PubMed ID: 37228606
[TBL] [Abstract][Full Text] [Related]
6. Diffusion and Relaxation Edited Proton NMR Spectroscopy of Plasma Reveals a High-Fidelity Supramolecular Biomarker Signature of SARS-CoV-2 Infection.
Lodge S; Nitschke P; Kimhofer T; Wist J; Bong SH; Loo RL; Masuda R; Begum S; Richards T; Lindon JC; Bermel W; Reinsperger T; Schaefer H; Spraul M; Holmes E; Nicholson JK
Anal Chem; 2021 Mar; 93(8):3976-3986. PubMed ID: 33577736
[TBL] [Abstract][Full Text] [Related]
7. Post-COVID-19 Symptoms 2 Years After SARS-CoV-2 Infection Among Hospitalized vs Nonhospitalized Patients.
Fernández-de-Las-Peñas C; Rodríguez-Jiménez J; Cancela-Cilleruelo I; Guerrero-Peral A; Martín-Guerrero JD; García-Azorín D; Cornejo-Mazzuchelli A; Hernández-Barrera V; Pellicer-Valero OJ
JAMA Netw Open; 2022 Nov; 5(11):e2242106. PubMed ID: 36378309
[TBL] [Abstract][Full Text] [Related]
8. Systemic Perturbations in Amine and Kynurenine Metabolism Associated with Acute SARS-CoV-2 Infection and Inflammatory Cytokine Responses.
Lawler NG; Gray N; Kimhofer T; Boughton B; Gay M; Yang R; Morillon AC; Chin ST; Ryan M; Begum S; Bong SH; Coudert JD; Edgar D; Raby E; Pettersson S; Richards T; Holmes E; Whiley L; Nicholson JK
J Proteome Res; 2021 May; 20(5):2796-2811. PubMed ID: 33724837
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of inflammatory biomarkers and vitamins in hospitalized patients with SARS-CoV-2 infection and post-COVID syndrome.
Krčmová LK; Javorská L; Matoušová K; Šmahel P; Skála M; Kopecký M; Suwanvecho C; Přívratská N; Turoňová D; Melichar B
Clin Chem Lab Med; 2024 May; 62(6):1217-1227. PubMed ID: 38374668
[TBL] [Abstract][Full Text] [Related]
10. Sex-Related Differences in Long-COVID-19 Syndrome.
Pelà G; Goldoni M; Solinas E; Cavalli C; Tagliaferri S; Ranzieri S; Frizzelli A; Marchi L; Mori PA; Majori M; Aiello M; Corradi M; Chetta A
J Womens Health (Larchmt); 2022 May; 31(5):620-630. PubMed ID: 35333613
[No Abstract] [Full Text] [Related]
11. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
[TBL] [Abstract][Full Text] [Related]
12. Immunofibrotic drivers of impaired lung function in postacute sequelae of SARS-CoV-2 infection.
Chun HJ; Coutavas E; Pine AB; Lee AI; Yu VL; Shallow MK; Giovacchini CX; Mathews AM; Stephenson B; Que LG; Lee PJ; Kraft BD
JCI Insight; 2021 Jul; 6(14):. PubMed ID: 34111030
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of post-acute COVID-19 syndrome symptoms at different follow-up periods: a systematic review and meta-analysis.
Alkodaymi MS; Omrani OA; Fawzy NA; Shaar BA; Almamlouk R; Riaz M; Obeidat M; Obeidat Y; Gerberi D; Taha RM; Kashour Z; Kashour T; Berbari EF; Alkattan K; Tleyjeh IM
Clin Microbiol Infect; 2022 May; 28(5):657-666. PubMed ID: 35124265
[TBL] [Abstract][Full Text] [Related]
14. Molecular Phenomic Approaches to Deconvolving the Systemic Effects of SARS-CoV-2 Infection and Post-acute COVID-19 Syndrome.
Nicholson JK
Phenomics; 2021; 1(4):143-150. PubMed ID: 35233558
[TBL] [Abstract][Full Text] [Related]
15. Kynurenine serves as useful biomarker in acute, Long- and Post-COVID-19 diagnostics.
Bizjak DA; Stangl M; Börner N; Bösch F; Durner J; Drunin G; Buhl JL; Abendroth D
Front Immunol; 2022; 13():1004545. PubMed ID: 36211365
[TBL] [Abstract][Full Text] [Related]
16. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
[TBL] [Abstract][Full Text] [Related]
17. Alteration of Smell and Taste in Asymptomatic and Symptomatic COVID-19 Patients in Sicily, Italy.
Bianco MR; Modica DM; Drago GD; Azzolina A; Mattina G; De Natale M; Rossi G; Amata M; Canzoneri G; Manganaro G; Di Gregorio F; Russo R; Pricoco S; Saita V; Allegra E
Ear Nose Throat J; 2021 Apr; 100(2_suppl):182S-185S. PubMed ID: 33350319
[TBL] [Abstract][Full Text] [Related]
18. Multiorgan impairment in low-risk individuals with post-COVID-19 syndrome: a prospective, community-based study.
Dennis A; Wamil M; Alberts J; Oben J; Cuthbertson DJ; Wootton D; Crooks M; Gabbay M; Brady M; Hishmeh L; Attree E; Heightman M; Banerjee R; Banerjee A;
BMJ Open; 2021 Mar; 11(3):e048391. PubMed ID: 33785495
[TBL] [Abstract][Full Text] [Related]
19. Integrative Modeling of Plasma Metabolic and Lipoprotein Biomarkers of SARS-CoV-2 Infection in Spanish and Australian COVID-19 Patient Cohorts.
Masuda R; Lodge S; Nitschke P; Spraul M; Schaefer H; Bong SH; Kimhofer T; Hall D; Loo RL; Bizkarguenaga M; Bruzzone C; Gil-Redondo R; Embade N; Mato JM; Holmes E; Wist J; Millet O; Nicholson JK
J Proteome Res; 2021 Aug; 20(8):4139-4152. PubMed ID: 34251833
[TBL] [Abstract][Full Text] [Related]
20. Exploration of Human Serum Lipoprotein Supramolecular Phospholipids Using Statistical Heterospectroscopy in
Masuda R; Lodge S; Whiley L; Gray N; Lawler N; Nitschke P; Bong SH; Kimhofer T; Loo RL; Boughton B; Zeng AX; Hall D; Schaefer H; Spraul M; Dwivedi G; Yeap BB; Diercks T; Bernardo-Seisdedos G; Mato JM; Lindon JC; Holmes E; Millet O; Wist J; Nicholson JK
Anal Chem; 2022 Mar; 94(10):4426-4436. PubMed ID: 35230805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
